Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:17 pm Purchase | 2024-09-30 | 13G | Nektar Therapeutics NKTR | EVENTIDE ASSET MANAGEMENT LLC | 9,400,000 5.110% | 9,400,000 (New Position) | Filing History |
| 2024-11-14 09:18 am Sale | 2024-09-30 | 13G | Nektar Therapeutics NKTR | Deep Track Capital, LP | 15,922,655 8.650% | -2,477,345 (-13.46%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Nektar Therapeutics NKTR | BlackRock Inc. BLK | 15,969,345 8.700% | 0 (Unchanged) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Nektar Therapeutics NKTR | BlackRock Inc. BLK | 15,969,345 8.700% | 7,365,023 (+85.60%) | Filing History |
| 2024-03-15 4:18 pm Purchase | 2024-03-06 | 13G | Nektar Therapeutics NKTR | TCG Crossover GP II, LLC | 20,046,350 9.900% | 20,046,350 (New Position) | Filing History |
| 2024-02-14 5:03 pm Sale | 2023-12-31 | 13G | Nektar Therapeutics NKTR | RA CAPITAL MANAGEMENT LLC | 0 0.000% | -18,700,000 (Position Closed) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Nektar Therapeutics NKTR | Citadel Advisors LLC | 5,635,132 3.000% | -4,094,620 (-42.08%) | Filing History |
| 2024-02-14 08:50 am Purchase | 2023-12-31 | 13G | Nektar Therapeutics NKTR | Deep Track Capital, LP | 18,400,000 9.650% | 6,097,763 (+49.57%) | Filing History |
| 2024-02-13 5:09 pm Sale | 2023-12-29 | 13G | Nektar Therapeutics NKTR | Vanguard Group Inc | 12,042,873 6.310% | -13,314 (-0.11%) | Filing History |
| 2023-08-17 4:30 pm Purchase | 2023-08-07 | 13G | Nektar Therapeutics NKTR | RA CAPITAL MANAGEMENT LLC | 18,700,000 9.800% | 18,700,000 (New Position) | Filing History |
| 2023-07-10 2:09 pm Sale | 2023-07-10 | 13G | Nektar Therapeutics NKTR | Invesco Ltd. IVZ | 5,535,430 2.900% | -31,792,043 (-85.17%) | Filing History |
| 2023-07-10 10:41 am Sale | 2023-06-30 | 13G | Nektar Therapeutics NKTR | Vanguard Group Inc | 12,056,187 6.370% | -11,009,588 (-47.73%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Nektar Therapeutics NKTR | BlackRock Inc. BLK | 8,604,322 4.500% | -9,696,352 (-52.98%) | Filing History |
| 2023-07-07 1:28 pm Sale | 2023-06-30 | 13G | Nektar Therapeutics NKTR | PRIMECAP MANAGEMENT CO | 8,149,876 4.310% | -7,509,177 (-47.95%) | Filing History |
| 2023-07-03 4:02 pm Purchase | 2023-06-23 | 13G | Nektar Therapeutics NKTR | Citadel Advisors LLC | 9,729,752 5.100% | 9,729,752 (New Position) | Filing History |
| 2023-05-05 11:52 am Sale | 2023-04-30 | 13G | Nektar Therapeutics NKTR | BlackRock Inc. BLK | 18,300,674 9.700% | -17,627,419 (-49.06%) | Filing History |
| 2023-04-14 4:34 pm Purchase | 2023-04-04 | 13G | Nektar Therapeutics NKTR | Deep Track Capital, LP | 12,302,237 6.500% | 12,302,237 (New Position) | Filing History |
| 2023-02-09 4:01 pm Sale | 2022-12-31 | 13G | Nektar Therapeutics NKTR | PRIMECAP MANAGEMENT CO | 15,659,053 8.330% | -1,753,369 (-10.07%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Nektar Therapeutics NKTR | Vanguard Group Inc | 23,065,775 12.270% | 4,553,864 (+24.60%) | Filing History |
| 2023-02-06 3:02 pm Sale | 2022-12-30 | 13G | Nektar Therapeutics NKTR | WELLINGTON MANAGEMENT CO LLP | 0 0.000% | -11,383,721 (Position Closed) | Filing History |